Analysis of transforming growth factor (TGF)-α/epidermal growth factor receptor, hepatocyte growth factor/c-met, TGF-β receptor type II, and p53 expression in human hepatocellular carcinomas

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1059-1066

  Kiss, Andras ^a   Wang, Neng Jin ^b   Xie, Jin Ping ^c   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Liver Cancer Institute   (China)

^c CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030857813     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Harris, C. C., and Sun, T. Multifactorial etiology of human liver cancer. Carcinogenesis (Lond.), 5: 697-701, 1984.
2. Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van Der Watt, J. J., Vincent, T. J., and Purchase, I. F. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer, 51: 713-726, 1985.
3. Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J., and Henderson, B. E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China. Cancer Res., 49: 2506-2509, 1989.
4. Ozturk, M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338: 1356-1359, 1991.
5. Fausto, N. Growth factors in liver development, regeneration and carcinogenesis. Prog. Growth Factor Res., 3: 219-234, 1991.
6. Jirtle, R. L. Liver Regeneration and Carcinogenesis: Cellular and Molecular Mechanisms. New York: Academic Press, 1995.
7. Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., and Thorgeirsson, S. S. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54: 281-285, 1994.
8. Mead, J. E., and Fausto, N. Transforming growth factor a may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA, 86: 1558-1562, 1989.
9. Tomiya, T., and Fujiwara, K. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme linked immunosorbent assay. Hepatology, 18: 304-308, 1993.
10. Tabor, E., Farshid, M., Di Bisceglie, A., and Hsia, C. C. Increased expression of transforming growth factor a after transfection of a human hepatoblastoma cell line with the hepatitis B virus. J. Med. Virol., 17: 271-273, 1992.
11. Hsia, C. C., Thorgeirsson, S. S., and Tabor, E. Expression of hepatitis B surface and core antigens and transforming growth factor-α in "oval cells" of the liver in patients with hepatocellular carcinoma. J. Med. Virol., 43: 216-221, 1994.
12. Schaff, Z. S., Hsia, C. C., Sarosi, I., and Tabor, E. Overexpression of transforming growth factor-α in hepatocellular carcinoma and focal nodular hyperplasia from European patients. Hum. Pathol., 25: 644-651, 1994.
13. Lee, G. H., Merlino, G., and Fausto, N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res., 52: 5162-5170, 1992.
14. Takagi, H., Sharp, R., Hammermeister, C., Goodrow, T., Bradley, M. O., Fausto, N., and Merlino, G. Molecular and genetic analysis of liver oncogenesis in transforming growth factor α transgenic mice. Cancer Res., 52: 5171-5177, 1993.
15. Tamano, S., Merlino, G. T., and Ward, J. M. Rapid development of hepatic tumors in transforming growth factor α transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis (Lond.), 15: 1791-1798, 1994.
16. Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., and Merlino, G. T. TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61: 1137-1146, 1990.
17. Sandgren, E. P., Luetteke, N. C., Qiu, T. H., Palmiter, R. D., Brinster, R. L., and Lee, D. C. Transforming growth factor α dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell. Biol., 13: 320-330, 1993.
18. Nakopoulou, L., Stefanaki, K., Filaktopoulos, D., and Giannopoulou, I. c-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study. Histol. Histopathol., 9: 677-682, 1994.
19. Morimitsu, Y., Hsia, C. C. Kojiro, M., and Tabor, E. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma. Hum. Pathol., 26: 1126-1132, 1995.
20. Yamaguchi, K., Carr, B. I., and Nalesnik, M. A. Concomitant and isolated expression of TGF-α and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J. Surg. Oncol., 58: 240-245, 1995.
21. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kitamura, N. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature (Lond.), 373: 702-705, 1995.
22. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature (Lond.), 373: 699-702, 1995.
23. Matsumoto, K., and Nakamura, T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncog., 3: 27-54, 1992.
24. Shiota, G., Rhoads, D. B., Wang, T. C. Nakamura, T., and Schmidt, E. V. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA, 89: 373-377, 1992.
25. Shiota, G., Kawasaki, H., Nakamura, T., and Schmidt, E. V. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C. Res. Commun. Mol. Pathol. Pharm., 85: 271-278, 1994.
26. Liu, M. L., Mars, W. M., and Michalopoulos, G. K. Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Carcinogenesis (Lond.), 16: 841-843, 1995.
27. Shiota, G., Wang, C. T., Nakamura, T., and Schmidt, E. V. Hepatocyte growth factor transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology, 19: 962-972, 1994.
28. Santoni-Rugiu, E., Preisegger, K. H., Kiss, A., Audolfsson, T., Shiota, G., Schmidt, E. V., and Thorgeirsson, S. S. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 93: 9577-9582, 1996.
29. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M. L., Kmiecik, T. E., Vande Woude, G. F., and Aaronson, S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (Washington DC). 251: 802-804, 1991.
30. Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., and Vande Woude, G. F. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (Lond.), 311: 29-33, 1984.
31. Cooper, C. S., Tempest, P. R., Beckman, M. P., Heldin, C. H., and Brookes, P. Amplification and overexpression of the c-met gene in spontaneously transformed NIH3T3 mouse fibroblasts. EMBO J., 5: 2623-2628, 1986.
32. Boix, L., Rosa, J. L., Ventura, F., Castells, A., Bruix, J., Rodes, J., and Bartrons, R. c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology, 19: 88-91, 1994.
33. Grigioni, W. F., Fiorentino, M., D'Errico, A., Ponzetto, A., Crepaldi, T., Prat, M., and Comoglio, P. M. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology, 21: 1543-1546, 1995.
34. Prat, M., Narsimhan, R. P., Crepaldi, T., Nicotra, M. R., Natali, P. G., and Comoglio, P. M. The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer, 49: 323-328, 1991.
35. Carr, B. I., Hayashi, I., Branum, E. L., and Moses, H. L. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res., 44: 2230-2234, 1986.
36. McMahon, I. B., Richards, W. L., del Campo, A. A., Song, M-K. H., and Thorgeirsson, S. S. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res., 46: 4665-4671, 1986.
37. Nagy, P., Schaff, Z. S., and Lapis, K. Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases. Hepatology, 14: 269-273, 1991.
38. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., and Thorgeirsson, S. S. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA, 92: 2572-2576, 1995.
39. Shirai, Y., Kawata, S., Ito, N., Tamura, S., Takaishi, S., Kiso, S., Tsushima, H., and Matsuzawa, Y. Elevated levels of plasma transforming growth factor-β in patients with hepatocellular carcinoma. Jpn. J. Cancer Res., 83: 676-679, 1992.
40. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massagué, J. TGFβ signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
41. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C. H., and Miyazono, K. Cloning of TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell, 75: 681-692, 1993.
42. Inagaki, M., Moustakas, A., Lin, H. Y., Lodish, H. F., and Carr, B. I. Growth inhibition by transforming growth factor β(TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc. Natl. Acad. Sci. USA, 90: 5359-5363, 1993.
43. Attisano, L., Wrana, J. L., Lopez-Casillas, F., and Massagué, J. TGF-β receptors and actions. Biochim. Biophys. Acta, 1222: 71-80, 1994.
44. Sue, S. R., Chari, R. S., Kong, F. M., Mills, J. J., Fine, R. L., Jirtle, R. L., and Meyers, W. C. Transforming growth factor-β receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surg., 222: 171-178, 1995.
45. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
46. Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S. E. M., Salter, D. M., Bird, C. C., Wyllie, A. H., Hooper, M. L., and Clarke, A. R. Tumor incidence, spectrum and ploidy in mice with large deletion in the p53 gene. Oncogene, 9: 603-609, 1994.
47. Feitelson, M. A., Zhu, M., Duan, L. X., and London, W. T. Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene, 8: 1109-1117, 1993.
48. Ueda, H., Ullrich, S. J., Gangemi, J. D., Rappel, C. A., Ngo, L., Feitelson, M. A., and Jay, G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet., 9: 41-47, 1995.
49. Wang, X. W., Gibson, M. K., Vermeulen, W., Yen, H., Forrester, K., Sturzbecher, H. W., Hoeijmakers, J. H. J., and Harris, C. C. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res., 55: 6012-6016, 1995.
50. Aguilar, F., Hussain, S. P., and Cerutti, P. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. USA, 90: 8586-8590, 1993.
51. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
52. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
53. Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., and Cerutti, P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science (Washington DC), 264: 1317-1319, 1994.
54. Zambetti, G. P., and Levine, A. J. A comparison of the biological activities of wild type and mutant p53. FASEB J., 7: 855-865, 1993.
55. Wolf, H. K., Zarnegar, R., and Michalopoulos, G. K. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology, 14: 488-494, 1991.
56. Shimaoka, S., Imai, R., and Ogawa, H. Dermal papilla cells express hepatocyte growth factor. J. Dermatol. Sci., 7: 79-83, 1994.
57. Saitoh, K., Takahashi, H., Sawada, N., and Parsons, P. G. Detection of the c-met proto-oncogene product in normal skin and tumors of melanocytic origin. J. Pathol., 174: 191-199, 1994.
58. Schmid, P., Cox, D., Bilbe, G., McMaster, G., Morrison, C., Stähelin, H., Lüscher, N., and Seiler, W. TGF-βs, and TGF-β type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J. Pathol., 171: 191-197, 1993.
59. Schaff, Z. S., Sarosi, I., Hsia, C. C., Kiss, A., and Tabor, E. p53 in malignant and benign liver lesions. Eur. J. Cancer, 31A: 1847-1850, 1995.
60. Maher, J. J. Cell-specific expression of hepatocyte growth factor in liver. J. Clin. Invest., 91: 2244-2252, 1993.
61. Hu, Z., Evarts, R. P., Fujio, K., Marsden, E. R., and Thorgeirsson, S. S. Expression of hepatocyte growth factor and c-met during hepatic differentiation and liver development in the rat. Am. J. Pathol., 142: 1823-1830, 1993.
62. Yamaguchi, K., Nalesnik, M. A., and Michalopoulos, G. K. Hepatocyte growth factor mRNA in human liver cirrhosis as evidenced by in situ hybridization. Scand. J. Gastroenterol., 31: 921-927, 1996.
63. Sakaguchi, H., Seki, S., Tsubouchi, H., Daikuhara, Y., Niitani, Y., and Kobayashi, K. Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology, 19: 1157-1163, 1994.
64. Yoshinaga, Y., Matsuno, Y., Fujita, S., Nakamura, T., Kikuchi, M., Shimosato, Y., and Hirohashi, S. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn. J. Cancer Res., 84: 1150-1158, 1993.
65. Nakayama, N., Kashiwazaki, H., Kobayashi, N., Hamada, J., Matsumoto, K., Nakamura, T., and Takeichi, N. Differing distribution of hepatocyte growth factor-positive cells in the liver of LEC rats with acute hepatitis, chronic hepatitis and hepatoma. Jpn. J. Cancer Res., 86: 5-9, 1995.
66. Bedossa, P., Peltier, E., Terris, B., Franco, D., and Poynard, T. Transforming growth factor-β 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology, 21: 760-766, 1995.